A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of DP-R206 and Bonvia for the improvement of Vitamin D In postmenopausal women with Osteoporosis ; DIOS study

Trial Profile

A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of DP-R206 and Bonvia for the improvement of Vitamin D In postmenopausal women with Osteoporosis ; DIOS study

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2016

At a glance

  • Drugs Colecalciferol/ibandronic-acid (Primary) ; Ibandronic acid
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Acronyms DIOS
  • Sponsors DreamPharma Corporation
  • Most Recent Events

    • 31 Oct 2016 Status changed from recruiting to completed.
    • 09 May 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000415).
    • 26 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top